Biolinq Incorporated

Introducing Biolinq ShineTM

SAN DIEGO, United States · Founded 2015 · $158.0M raised

Employees
51–200
Founded
2015
Business Model
B2C
Total Funding
$158.0M
Last Round
$100.0M Series CApr 2025
Rounds
2

About

Biolinq develops biowearable biosensing platforms for metabolic health monitoring. Biolinq Shine is the first FDA-cleared needle-free continuous glucose sensor.

Summary

Biolinq Incorporated is a Biotech company based in SAN DIEGO, United States, founded in 2015. It has raised $158.0M in total across 2 rounds, most recently a $100.0M Series C round in Apr 2025. Investors include Alpha Wave Ventures.

Tech & App Stack

15 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series CSeries CApr 2025
$100.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies